BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bots STF, Hoeben RC. Non-Human Primate-Derived Adenoviruses for Future Use as Oncolytic Agents? Int J Mol Sci 2020;21:E4821. [PMID: 32650405 DOI: 10.3390/ijms21144821] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
Number Citing Articles
1 Marquez-Martinez S, Vijayan A, Khan S, Zahn R. Cell entry and innate sensing shape adaptive immune responses to adenovirus-based vaccines. Curr Opin Immunol 2023;80:102282. [PMID: 36716578 DOI: 10.1016/j.coi.2023.102282] [Reference Citation Analysis]
2 Bots STF, Landman SL, Rabelink MJWE, van den Wollenberg DJM, Hoeben RC. Immunostimulatory Profile of Cancer Cell Death by the AdV-Lumc007-Derived Oncolytic Virus 'GoraVir' in Cultured Pancreatic Cancer Cells. Viruses 2023;15. [PMID: 36851497 DOI: 10.3390/v15020283] [Reference Citation Analysis]
3 Bots STF, Kemp V, Dautzenberg IJC, Hoeben RC. Genome Analyses of Ten New Ape Adenoviruses with Similarity to Human Mastadenovirus C. IJMS 2022;23:9832. [DOI: 10.3390/ijms23179832] [Reference Citation Analysis]
4 Biegert GWG, Rosewell Shaw A, Suzuki M. Current development in adenoviral vectors for cancer immunotherapy. Mol Ther Oncolytics 2021;23:571-81. [PMID: 34938857 DOI: 10.1016/j.omto.2021.11.014] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
5 Chen J, Wang J, Zhang J, Ly H. Advances in Development and Application of Influenza Vaccines. Front Immunol 2021;12:711997. [PMID: 34326849 DOI: 10.3389/fimmu.2021.711997] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
6 Cimolai N. Preliminary concerns with vaccine vectors. Mutagenesis 2020;35:359-60. [PMID: 32785590 DOI: 10.1093/mutage/geaa020] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
7 Greber UF, Gomez-Gonzalez A. Adenovirus - a blueprint for gene delivery. Curr Opin Virol 2021;48:49-56. [PMID: 33892224 DOI: 10.1016/j.coviro.2021.03.006] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 4.5] [Reference Citation Analysis]
8 Tessarollo NG, Domingues ACM, Antunes F, Luz JCDSD, Rodrigues OA, Cerqueira OLD, Strauss BE. Nonreplicating Adenoviral Vectors: Improving Tropism and Delivery of Cancer Gene Therapy. Cancers (Basel) 2021;13:1863. [PMID: 33919679 DOI: 10.3390/cancers13081863] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
9 Giménez-Roig J, Núñez-Manchón E, Alemany R, Villanueva E, Fillat C. Codon Usage and Adenovirus Fitness: Implications for Vaccine Development. Front Microbiol 2021;12:633946. [PMID: 33643266 DOI: 10.3389/fmicb.2021.633946] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
10 Bulcha JT, Wang Y, Ma H, Tai PWL, Gao G. Viral vector platforms within the gene therapy landscape. Signal Transduct Target Ther 2021;6:53. [PMID: 33558455 DOI: 10.1038/s41392-021-00487-6] [Cited by in Crossref: 203] [Cited by in F6Publishing: 202] [Article Influence: 101.5] [Reference Citation Analysis]
11 O'Brien B, Goodridge L, Ronholm J, Nasheri N. Exploring the potential of foodborne transmission of respiratory viruses. Food Microbiol 2021;95:103709. [PMID: 33397626 DOI: 10.1016/j.fm.2020.103709] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
12 Hensen LCM, Hoeben RC, Bots STF. Adenovirus Receptor Expression in Cancer and Its Multifaceted Role in Oncolytic Adenovirus Therapy. Int J Mol Sci 2020;21:E6828. [PMID: 32957644 DOI: 10.3390/ijms21186828] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]